Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00244
|
|||||
| Drug Name |
L-threonine
|
|||||
| Synonyms |
Threonine
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Ulcerative colitis [ICD11:DD71] | preclinical | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C4H9NO3
|
|||||
| Canonical SMILES |
CC(C(C(=O)O)N)O
|
|||||
| InChI |
InChI=1S/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3+/m1/s1
|
|||||
| InChIKey |
AYFVYJQAPQTCCC-GBXIJSLDSA-N
|
|||||
| CAS Number |
CAS 72-19-5
|
|||||
| Pharmaceutical Properties | Molecular Weight | 119.12 | Topological Polar Surface Area | 83.6 | ||
| Heavy Atom Count | 8 | Rotatable Bond Count | 2 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
-2.9
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103023885
,103059716
,103247439
,103827637
,104311631
,10533896
,117393381
,117688069
,118055275
,124384984
,124385323
,125310811
,15119834
,24697487
,24889191
,24900195
,24900531
,24900544
,24902203
,29225282
,3134685
,3488
,46506798
,50054671
,57323322
,57580774
,57653332
,57654668
,76633579
,7847109
,7890772
,8138261
,8143617
,8153965
,828064
,838580
,841559
,85164897
,87325083
,87350315
,87576218
,92298406
,92710680
,93617430
,96021832
,96021834
,96021835
,99224320
,99452994
,99453694
|
|||||
| ChEBI ID |
ChEBI:16857
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | ASCT2 | Transporter Info | Alanine/serine/cysteine/threonine transporter 2 | Substrate | [2] | |
| References | ||||||
| 1 | ClinicalTrials.gov (NCT02423460) Threonine Requirement in IBD Adults and Healthy Adult Controls | |||||
| 2 | D-Serine Is a Substrate for Neutral Amino Acid Transporters ASCT1/SLC1A4 and ASCT2/SLC1A5, and Is Transported by Both Subtypes in Rat Hippocampal Astrocyte Cultures. PLoS One. 2016 Jun 7;11(6):e0156551. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.